advertisement

Oculus

2.1 Conjunctiva (48)

Showing records 1 to 25

Display all abstracts in classification 2.1 Conjunctiva

Search within classification 2.1 Conjunctiva
84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Yagi-Yaguchi Y
Diagnostics (Basel, Switzerland) 2020; 10:
85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Mylla Boso AL
Clinical Ophthalmology 2020; 14: 103-111
84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Guarnieri A
BMC Ophthalmology 2020; 20: 12
84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Guarnieri A
International Ophthalmology 2020; 40: 741-751
84838 Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
Shen W
Journal of Ophthalmology 2019; 2019: 9798272
85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Rogov AG
Oxidative medicine and cellular longevity 2020; 2020: 8956504
85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Baiocchi S
Eye and vision (London, England) 2020; 7: 15
84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Carnero E
BMC Ophthalmology 2020; 20: 12
84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Carnero E
International Ophthalmology 2020; 40: 741-751
85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Goleva TN
Oxidative medicine and cellular longevity 2020; 2020: 8956504
84838 Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
Huang B
Journal of Ophthalmology 2019; 2019: 9798272
84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Carnero E
BMC Ophthalmology 2020; 20: 12
85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Gasperi E
Clinical Ophthalmology 2020; 14: 103-111
84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Carnero E
International Ophthalmology 2020; 40: 741-751
84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Kojima T
Diagnostics (Basel, Switzerland) 2020; 10:
85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Mazzotta C
Eye and vision (London, England) 2020; 7: 15
84838 Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
Yang J
Journal of Ophthalmology 2019; 2019: 9798272
84873 The Effects of 3% Diquafosol Sodium Eye Drops on Tear Function and the Ocular Surface of Cu, Zn-Superoxide Dismutase-1 () Knockout Mice Treated with Antiglaucoma Eye Medications
Higa K
Diagnostics (Basel, Switzerland) 2020; 10:
85195 In vivo confocal microscopy: qualitative investigation of the conjunctival and corneal surface in open angle glaucomatous patients undergoing the XEN-Gel implant, trabeculectomy or medical therapy
Sgheri A
Eye and vision (London, England) 2020; 7: 15
85151 Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride
Sukhanova EI
Oxidative medicine and cellular longevity 2020; 2020: 8956504
84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Bleau AM
International Ophthalmology 2020; 40: 741-751
84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Bleau AM
BMC Ophthalmology 2020; 20: 12
85089 Impact of Ocular Surface Disease Treatment in Patients with Glaucoma
Fernandes L
Clinical Ophthalmology 2020; 14: 103-111
84702 Relationship between OSDI questionnaire and ocular surface changes in glaucomatous patients
Bleau AM
International Ophthalmology 2020; 40: 741-751
84877 Ocular surface analysis and automatic non-invasive assessment of tear film breakup location, extension and progression in patients with glaucoma
Bleau AM
BMC Ophthalmology 2020; 20: 12

Issue 21-1

Select Issue


advertisement

Oculus